- DocumentResumetéléversé parAura Rachmawati
- DocumentClinical Pathway IPDtéléversé parAura Rachmawati
- DocumentPANDUAN IMPLEMENTASI KODE EMERGENSI.docxtéléversé parAura Rachmawati
- DocumentDM TPE 2 USIA LANJUT.pdftéléversé parAura Rachmawati
- Document297570846-FORMULIR-DPJP.docxtéléversé parAura Rachmawati
- Document377977395 Panduan Code Redtéléversé parAura Rachmawati
- DocumentPanduan Implementasi Kode-kode Emergensitéléversé parAura Rachmawati
- DocumentPANDUAN_IMPLEMENTASI_KODE-KODE_EMERGENSI.docxtéléversé parAura Rachmawati
- Document297570846-FORMULIR-DPJPtéléversé parAura Rachmawati
- Document297570846-FORMULIR-DPJP.docxtéléversé parAura Rachmawati
- DocumentDM TPE 2 USIA LANJUT.pdftéléversé parAura Rachmawati
- DocumentDM pada usia lanjut.pdftéléversé parAura Rachmawati
- Documentinfodatin-diabetes.pdftéléversé parAura Rachmawati
- DocumentLeaflet Supri 1téléversé parAura Rachmawati
- DocumentCairan Dan Elektrolit Des 09téléversé parAura Rachmawati
- DocumentSubclinical Hypothyroid in Children and Adolescentstéléversé parAura Rachmawati
- Documentdetection of thyroid dysfunction in early pregnancy.pdftéléversé parAura Rachmawati
- Documentjcem-44-3-481--téléversé parAura Rachmawati
- DocumentSchneider_et_al-2013-CA-_A_Cancer_Journal_for_Clinicians.pdftéléversé parAura Rachmawati
- Documentdokumen.tips_laporan-kasus-hernia-55844c715fead.docxtéléversé parAura Rachmawati
- Documentnejmoa1310214[1]téléversé parAura Rachmawati
- DocumentARIA_PG_08_View_WM[1].pdftéléversé parAura Rachmawati
- Document02-Pelayanan_Imunisasi[1].pdftéléversé parAura Rachmawati
- DocumentSchneider_et_al-2013-CA-_A_Cancer_Journal_for_Clinicians.pdftéléversé parAura Rachmawati
- DocumentTargeting the RET Pathway in Thyroid Cancertéléversé parAura Rachmawati
- DocumentPhase II Trial of Sorafenib in Advanced Thyroid Cancertéléversé parAura Rachmawati
- DocumentChemotherapy for Colorectalncancertéléversé parAura Rachmawati
- DocumentPrevalence and Risk Factors of Subclinical Thyroid Diseasetéléversé parAura Rachmawati
- DocumentPrevalence and Risk Factors of Subclinical Thyroid Diseasetéléversé parAura Rachmawati
- DocumentThyroid Cancer Emerging Role for Targeted Therapiestéléversé parAura Rachmawati
- DocumentProgress in Molecular Targeted Therapy for Thyroid Cancer Vandetanib in Medullary Thyroid Cancertéléversé parAura Rachmawati
- DocumentNew Treatment Modalities in Advanced Thyroid Cancertéléversé parAura Rachmawati
- DocumentNew Targeted Therapies for Thyroid Cancertéléversé parAura Rachmawati
- DocumentProgress in Molecular Targeted Therapy for Thyroid Cancer Vandetanib in Medullary Thyroid Cancertéléversé parAura Rachmawati
- DocumentNew Targeted Therapies for Thyroid Cancertéléversé parAura Rachmawati
- DocumentAJHO Apr15 10 Thyroidtéléversé parAura Rachmawati
- DocumentPinestreet.pptxtéléversé parAura Rachmawati
- DocumentDiabetes Control in Thyroid Diseasetéléversé parAura Rachmawati
- DocumentThyroid Size and Goiter Prevalence After Introduction of Iodized Salttéléversé parAura Rachmawati
- DocumentDetection of Thyroid Dysfunction in Early Pregnancytéléversé parAura Rachmawati
- DocumentProgress in Molecular Targeted Therapy for Thyroid Cancer Vandetanib in Medullary Thyroid Cancertéléversé parAura Rachmawati
- DocumentDetection of Thyroid Dysfunction in Early Pregnancytéléversé parAura Rachmawati
- DocumentAirAsia Prospectus Local English 20101029téléversé parAura Rachmawati
- DocumentCitibank Finaltéléversé parAura Rachmawati
- DocumentAsahi Glasstéléversé parAura Rachmawati
- DocumentAsahi Glasstéléversé parAura Rachmawati
- DocumentNokiatéléversé parAura Rachmawati
- Document1. Cover oktéléversé parAura Rachmawati
- DocumentData Imunisasi Di Puskesmas Tegal Angustéléversé parAura Rachmawati